Cargando…

Disaster hypertension and cardiovascular events in disaster and COVID‐19 pandemic

The incidence of large disasters has been increasing worldwide. This has led to a growing interest in disaster medicine. In this review, we report current evidence related to disasters and coronavirus disease‐2019 (COVID‐19) pandemic, such as cardiovascular diseases during disasters, management of d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narita, Keisuke, Hoshide, Satoshi, Tsoi, Kelvin, Siddique, Saulat, Shin, Jinho, Chia, Yook‐Chin, Tay, Jam Chin, Teo, Boon Wee, Turana, Yuda, Chen, Chen‐Huan, Cheng, Hao‐Min, Sogunuru, Guru Prasad, Wang, Tzung‐Dau, Wang, Ji‐Guang, Kario, Kazuomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Treatment and Management of Hypertension
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014319/ https://www.ncbi.nlm.nih.gov/pubmed/33527663 http://dx.doi.org/10.1111/jch.14192

Ejemplares similares

Applications of artificial intelligence for hypertension management
por: Tsoi, Kelvin, et al.
Publicado: (2021)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

Characteristics of hypertension in obstructive sleep apnea: An Asian experience
por: Hoshide, Satoshi, et al.
Publicado: (2021)

Hypertension in a multi‐ethnic Asian population of Singapore
por: Chan, Gek Cher, et al.
Publicado: (2020)

Hypertension and chronic kidney disease in Asian populations
por: Teo, Boon Wee, et al.
Publicado: (2021)

Dietary intervention for the management of hypertension in Asia
por: Chang, Hao‐Chih, et al.
Publicado: (2020)

Hypertension and erectile dysfunction: The role of endovascular therapy in Asia
por: Wang, Tzung‐Dau, et al.
Publicado: (2020)

Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe
por: Lin, Donna S.‐H., et al.
Publicado: (2020)

Current status of adherence interventions in hypertension management in Asian countries: A report from the HOPE Asia Network
por: Shin, Jinho, et al.
Publicado: (2020)

Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network
por: Turana, Yuda, et al.
Publicado: (2020)

Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE‐Asia Network
por: Chia, Yook‐Chin, et al.
Publicado: (2021)

Hypertension and stroke in Asia: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2020)

Non‐pharmacological management of hypertension
por: Verma, Narsingh, et al.
Publicado: (2021)

Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020)

Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension
por: Minh, Huynh Van, et al.
Publicado: (2021)

Long sleep duration and cardiovascular disease: Associations with arterial stiffness and blood pressure variability
por: Matsubayashi, Hideaki, et al.
Publicado: (2020)

Telemedicine in the management of hypertension: Evolving technological platforms for blood pressure telemonitoring
por: Wang, Ji‐Guang, et al.
Publicado: (2021)

Regional differences in office and self‐measured home heart rates in Asian hypertensive patients: AsiaBP@Home study
por: Tomitani, Naoko, et al.
Publicado: (2021)

The HOPE Asia network 2022 up‐date consensus statement on morning hypertension management
por: Kario, Kazuomi, et al.
Publicado: (2022)

Cardiovascular risk assessment tools in Asia
por: Zhang, Yuqing, et al.
Publicado: (2022)

Seven‐action approaches for the management of hypertension in Asia – The HOPE Asia network
por: Kario, Kazuomi, et al.
Publicado: (2022)

Standardized home blood pressure monitoring: Rationale behind the 722 protocol
por: Lin, Hung‐Ju, et al.
Publicado: (2022)

The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini‐review
por: Huang, Hui‐Chun, et al.
Publicado: (2022)

Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia
por: Fujiwara, Takeshi, et al.
Publicado: (2021)

Targets and management of hypertension in heart failure: focusing on the stages of heart failure
por: Miao, Huanhuan, et al.
Publicado: (2022)

Office blood pressure measurement: A comprehensive review
por: Siddique, Saulat, et al.
Publicado: (2021)

COVID‐19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network
por: Kario, Kazuomi, et al.
Publicado: (2020)

Hypertensive emergencies in Asia: A brief review
por: Kotruchin, Praew, et al.
Publicado: (2022)

Isolated systolic hypertension in Asia
por: Tsai, Tsung‐Ying, et al.
Publicado: (2020)

Insights on home blood pressure monitoring in Asia: Expert perspectives from 10 countries/regions
por: Wang, Ji‐Guang, et al.
Publicado: (2020)

Characteristics and control of the 24‐hour ambulatory blood pressure in patients with metabolic syndrome
por: Huang, Jian‐Feng, et al.
Publicado: (2021)

Who should be screened for primary aldosteronism? A comprehensive review of current evidence
por: Huang, Wei‐Chieh, et al.
Publicado: (2022)

Role of α1‐blockers in the current management of hypertension
por: Li, Hua, et al.
Publicado: (2022)

Sleep and nocturnal hypertension: Genes, environment, and individual profiles
por: Kario, Kazuomi
Publicado: (2022)

Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: The Japan Morning Surge Home Blood Pressure (J‐HOP) Study
por: Watanabe, Hiroaki, et al.
Publicado: (2021)

Neurodegenerative diseases and blood pressure variability: A comprehensive review from HOPE Asia
por: Turana, Yuda, et al.
Publicado: (2022)

Differences in ambulatory blood pressure profiles between Japanese and Thai patients with hypertension /suspected hypertension
por: Tomitani, Naoko, et al.
Publicado: (2020)

Rationale and design of a multicenter randomized study comparing the efficacy and safety of esaxerenone versus trichlormethiazide in patients with uncontrolled essential hypertension: EXCITE‐HT study
por: Kario, Kazuomi, et al.
Publicado: (2023)

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database
por: Shima, Daisuke, et al.
Publicado: (2020)

Cardiovascular Disease Prevention in Patients With Atherosclerotic Renovascular Disease‐Induced Resistant Hypertension: Further Considerations for 24‐Hour Blood Pressure Profiles
por: Narita, Keisuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nahp3o4mr0c59h1i53u5107alb